Molecular Diagnostics Market - Geographical Analysis
molecular diagnostic market is expected to be more than double by 2017 from its current market in 2012.•
stands at the second position in the global molecular diagnostic market. •
are expected to stand at 3rd, 4th and 5th slot respectively.• The
molecular diagnostics market is predicted to grow at a CAGR of 17% between 2012 and 2017.
Molecular Diagnostics Market – Company Wise Analysis
• The Roche molecular diagnostic share is greater than the combined share of Myriad Genetics and Qiagen which holds the 2nd and 3rd position respectively. • Abbott stands at the 4th spot and expected to generate sales worth US$ XXXX Million by the year 2017.• The Myriad Genetics molecular diagnostic sales were worth US$ XXXX Million in 2012.
Renub Research study titled
"Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis"
provides a comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics market.
This 158 page report with 81 Figures and 23 Tables studies the Global Molecular Diagnostics: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise molecular Diagnostics sales & Forecast 6) Molecular Diagnostic & Personalized Medicines 7) Clinical trials In Molecular Diagnostics Landscape.
The Report Covers the Following Points
• Global Molecular Diagnostic Market (2010-12) and Forecast (2013 to 2017)• Global Molecular Diagnostic Application Segment (Infectious Disease Testing, Virology Testing, HAI Testing, HPV Testing, Critical Care Infectious Testing, Blood Screening, Genetic Testing, Oncology Testing, Tissue Typing, Cardiovascular Disease Testing, Neurological Disorders Testing, Food Pathogen Detection Testing & Others) Market (2010-2012) and Forecast (2013 to 2017)• Molecular Diagnostic Technology Segment (PCR Based Test, PCR Related Technologies , Non-PCR Test, Fish & Innovations Testing, Biochips/Microarrays, Biosensors, Molecular Imaging, & Other Technologies) Market (2010-2012) and Forecast (2013 to 2017) • Molecular Diagnostic Geographical Distribution (US,
and Rest of World) Market (2010-2012) and Forecast (2013 to 2017) • Molecular Diagnostic Sales Company Wise Analysis (Roche, Abbott, Myriad Genetics, Qiagen, BioMérieux and Others ) Market (2010-2012) and Forecast (2013 to 2017) • Molecular Diagnostic and Road to Personalized medicine• Molecular Diagnostic Clinical Trial Statements (20 Clinical Trials Studied in the report)• Driving Forces & Challenges for Global Molecular Diagnostic Market
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.